These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The TREK K2P channels and their role in general anaesthesia and neuroprotection. Franks NP; Honoré E Trends Pharmacol Sci; 2004 Nov; 25(11):601-8. PubMed ID: 15491783 [TBL] [Abstract][Full Text] [Related]
4. TWIK-related two-pore domain potassium channel TREK-1 in carotid endothelium of normotensive and hypertensive mice. Pokojski S; Busch C; Grgic I; Kacik M; Salman W; Preisig-Müller R; Heyken WT; Daut J; Hoyer J; Köhler R Cardiovasc Res; 2008 Jul; 79(1):80-8. PubMed ID: 18339646 [TBL] [Abstract][Full Text] [Related]
5. Changes in expression of some two-pore domain potassium channel genes (KCNK) in selected brain regions of developing mice. Aller MI; Wisden W Neuroscience; 2008 Feb; 151(4):1154-72. PubMed ID: 18222039 [TBL] [Abstract][Full Text] [Related]
6. Stretch-activated potassium currents in the heart: Focus on TREK-1 and arrhythmias. Decher N; Kiper AK; Rinné S Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):223-232. PubMed ID: 28526352 [TBL] [Abstract][Full Text] [Related]
7. Polymodal Mechanism for TWIK-Related K+ Channel Inhibition by Local Anesthetic. Pavel MA; Chung HW; Petersen EN; Hansen SB Anesth Analg; 2019 Oct; 129(4):973-982. PubMed ID: 31124840 [TBL] [Abstract][Full Text] [Related]
8. Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Medhurst AD; Rennie G; Chapman CG; Meadows H; Duckworth MD; Kelsell RE; Gloger II; Pangalos MN Brain Res Mol Brain Res; 2001 Jan; 86(1-2):101-14. PubMed ID: 11165377 [TBL] [Abstract][Full Text] [Related]
9. Development of the First Two-Pore Domain Potassium Channel TWIK-Related K Vivier D; Soussia IB; Rodrigues N; Lolignier S; Devilliers M; Chatelain FC; Prival L; Chapuy E; Bourdier G; Bennis K; Lesage F; Eschalier A; Busserolles J; Ducki S J Med Chem; 2017 Feb; 60(3):1076-1088. PubMed ID: 28051863 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of two-pore-domain potassium (K(2P)) channels in the cardiovascular system. Wiedmann F; Schmidt C; Lugenbiel P; Staudacher I; Rahm AK; Seyler C; Schweizer PA; Katus HA; Thomas D Clin Sci (Lond); 2016 May; 130(9):643-50. PubMed ID: 26993052 [TBL] [Abstract][Full Text] [Related]
11. Mixing and matching TREK/TRAAK subunits generate heterodimeric K2P channels with unique properties. Blin S; Ben Soussia I; Kim EJ; Brau F; Kang D; Lesage F; Bichet D Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4200-5. PubMed ID: 27035965 [TBL] [Abstract][Full Text] [Related]
12. TREK Channel Family Activator with a Well-Defined Structure-Activation Relationship for Pain and Neurogenic Inflammation. Qiu Y; Huang L; Fu J; Han C; Fang J; Liao P; Chen Z; Mo Y; Sun P; Liao D; Yang L; Wang J; Zhang Q; Liu J; Liu F; Liu T; Huang W; Yang H; Jiang R J Med Chem; 2020 Apr; 63(7):3665-3677. PubMed ID: 32162512 [TBL] [Abstract][Full Text] [Related]
13. Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept. Borsotto M; Veyssiere J; Moha Ou Maati H; Devader C; Mazella J; Heurteaux C Br J Pharmacol; 2015 Feb; 172(3):771-84. PubMed ID: 25263033 [TBL] [Abstract][Full Text] [Related]
15. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact. Bayliss DA; Barrett PQ Trends Pharmacol Sci; 2008 Nov; 29(11):566-75. PubMed ID: 18823665 [TBL] [Abstract][Full Text] [Related]
16. A disulphide-linked heterodimer of TWIK-1 and TREK-1 mediates passive conductance in astrocytes. Hwang EM; Kim E; Yarishkin O; Woo DH; Han KS; Park N; Bae Y; Woo J; Kim D; Park M; Lee CJ; Park JY Nat Commun; 2014; 5():3227. PubMed ID: 24496152 [TBL] [Abstract][Full Text] [Related]
17. Formation of Functional Heterodimers by TREK-1 and TREK-2 Two-pore Domain Potassium Channel Subunits. Lengyel M; Czirják G; Enyedi P J Biol Chem; 2016 Jun; 291(26):13649-61. PubMed ID: 27129242 [TBL] [Abstract][Full Text] [Related]
18. Antidepressive and anxiolytic effects of ostruthin, a TREK-1 channel activator. Joseph A; Thuy TTT; Thanh LT; Okada M PLoS One; 2018; 13(8):e0201092. PubMed ID: 30110354 [TBL] [Abstract][Full Text] [Related]